Challenging drug targets are key to many future therapies. The elusive biology of such targets can only be studied within their native cellular environment. At CellarisBio, we crack challenging targets with unprecedented MICRO-TAG™ cellular target engagement platform.
Empower your drug discovery program with de novo discovery using DNA-Encoded Libraries (DELs) - all in the cell.
Upgrade your drug discovery data with real-time cell target engagement data. Reveal in-cell kinetics of drug-target engagement.
Enhance the breadth of your assays with highly sensitive cellular assays, from low nano-molar to high micro-molar levels.
MICRO-TAG™ platform uses the next-gen cell target engagement technology. It enables interrogation of targets without interfering with folding, localization and function.
Our platform has been tested and validated for a number of challenging target families, such as transcription factors, together with multiple therapeutic modalities.
Leverage the platform for challenging drug target. De-risk and accelerate drug discovery programs from discovery of candidates to validation, ranking and MoA analysis.
May 14th, 2025 at 10AM PST, 1PM EST
Reserve your seat!
DaysDays
HrsHours
MinsMinutes
SecsSeconds
The big day may have come and gone, but keep in touch as we’re always up to something new and exciting.
Copyright © 2025 CellarisBio - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Meet our team at AACR Conference in Chicago on April 25-30th, 2025.